Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction

Gastroenterology

Volumn 152, Issue 7, 2017, Pages 1671-1678

  Bouter, Kristien E ^a   van Raalte, Daniël H ^b,c   Groen, Albert K ^a,d   Nieuwdorp, Max ^a,b,c,e  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Diabetes; Fecal Transplantation; Gut Microbiota; Obesity

Indexed keywords

ARTICLE; DIET; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; INNATE IMMUNITY; INTESTINE FLORA; METABOLIC DISORDER; METABOLIC REGULATION; MICROBIAL COMMUNITY; MICROBIOME; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ANIMAL; BACTERIAL TRANSLOCATION; DIABETES MELLITUS, TYPE 2; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BACTERIAL TRANSLOCATION; DIABETES MELLITUS, TYPE 2; DIET; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNITY, INNATE; OBESITY;

EID: 85018198613     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.12.048     Document Type: Article

References (74)

1. 1 Whitman, W.B., Coleman, D.C., Wiebe, W.J., Prokaryotes: The unseen majority. Acad Sci U S A 95 (1998), 6578–6583.
2. 2 Sender, R., Fuchs, S., Milo, R., Are We really vastly outnumbered? revisiting the ratio of bacterial to host cells in humans. Cell 164 (2016), 337–340.
3. 3 Jandhyala, S.M., Talukdar, R., Subramanyam, C., et al. Role of the normal gut microbiota. World J Gastroenterol 21 (2015), 8787–8803.
4. 4 Jumpertz, R., Le, D.S., Turnbaugh, P.J., et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 94 (2011), 58–65.
5. 5 Lee, J.S., Polin, R.A., Treatment and prevention of necrotizing enterocolitis. Seminars in Neonat 8 (2003), 449–459.
6. 6 Biasucci, G., Rubini, M., Riboni, S., et al. Mode of delivery affects the bacterial community in the newborn gut. Early Hum Dev 86 (2010), 13–15.
7. 7 Jakobsson, H.E., Abrahamsson, T.R., Jenmalm, M.C., et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by Caesarean section. Gut 63 (2014), 559–566.
8. 8 Turroni, F., Peano, C., Pass, D.A., et al. Diversity of bifidobacteria within the infant gut microbiota. PLoS ONE, 7, 2012, e36957.
9. 9 Makino, H., Kushiro, A., Ishikawa, E., et al. Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant's microbiota. PLoS ONE, 8, 2013, e78331.
10. 10 Munyaka, P.M., Khafipour, E., Ghia, J.-E., External influence of early childhood establishment of gut microbiota and subsequent health implications. Front Pediatr, 2014, 2.
11. 11 Palmer, C., Bik, E.M., DiGiulio, D.B., et al. Development of the human infant intestinal microbiota. PLoS Biol, 5, 2007, e177.
12. 12 Faith, J.J., Guruge, J.L., Charbonneau, M., et al. The long-term stability of the human gut microbiota. Science (New York, N.Y.), 341, 2013 1237439-1237439.
13. 13 Yatsunenko, T., Rey, F.E., Manary, M.J., et al. Human gut microbiome viewed across age and geography. Nature 486 (2012), 222–227.
14. 14 Lee, Y.K., Mazmanian, S.K., Has the microbiota played a critical role in the evolution of the adaptive immune system?. Science (New York, N.Y.) 330 (2010), 1768–1773.
15. 15 Scheithauer, T.P.M., Dallinga-Thie, G.M., de Vos, W.M., et al. Causality of small and large intestinal microbiota in weight regulation and insulin resistance. Molec Metab 5 (2016), 759–770.
16. 16 Turnbaugh, P.J., Hamady, M., Yatsunenko, T., et al. A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
17. 17 Qin, J., Li, Y., Cai, Z., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (2012), 55–60.
18. 18 Plovier, H., Everard, A., Druart, C., et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med 23 (2017), 107–113.
19. 19 Rajilić-Stojanović, M., de Vos, W.M., The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 38 (2014), 996–1047.
20. 20 Finucane, M.M., Sharpton, T.J., Laurent, T.J., et al. A taxonomic signature of obesity in the microbiome? getting to the guts of the matter. PLOS ONE, 9, 2014, e84689.
21. 21 Karlsson, F.H., Tremaroli, V., Nookaew, I., et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498 (2013), 99–103.
22. 22 Forslund, K., Hildebrand, F., Nielsen, T., et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528 (2015), 262–266.
23. 23 Mozaffarian, D., Hao, T., Rimm, E.B., et al. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 364 (2011), 2392–2404.
24. 24 Chassaing, B., Koren, O., Goodrich, J.K., et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519 (2015), 92–96.
25. 25 Koeth, R.A., Wang, Z., Levison, B.S., et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19 (2013), 576–585.
26. 26 De Filippis, F., Pellegrini, N., Vannini, L., et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut 65 (2016), 1812–1821.
27. 27 Holscher, H.D., Bauer, L.L., Gourineni, V., et al. Agave inulin supplementation affects the fecal microbiota of healthy adults participating in a randomized, double-blind, placebo-controlled, crossover trial. J Nutr 145 (2015), 2025–2032.
28. 28 McNulty, N.P., Yatsunenko, T., Hsiao, A., et al. The Impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med, 3, 2011 106ra106-106ra106.
29. 29 Kadooka, Y., Sato, M., Imaizumi, K., et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 64 (2010), 636–643.
30. 30 Zeevi, D., Korem, T., Zmora, N., et al. Personalized nutrition by prediction of glycemic responses. Cell 163 (2015), 1079–1094.
31. 31 Levy, M., Thaiss Christoph, A., Zeevi, D., et al. Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell 163 (2015), 1428–1443.
32. 32 Griffin, N.W., Ahern, P.P., Cheng, J., et al. Prior Dietary Practices and Connections to a Human Gut Microbial Metacommunity Alter Responses to Diet Interventions. Cell Host Microbe 21 (2017), 84–96.
33. 33 Zhernakova, A., Kurilshikov, A., Bonder, M.J., et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352 (2016), 565–569.
34. 34 Maurice, C.F., Haiser, H.J., Turnbaugh, P.J., Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 152 (2013), 39–50.
35. 35 Korpela, K., Salonen, A., Virta, L.J., et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun, 7, 2016, 10410.
36. 36 Freedberg, D.E., Toussaint, N.C., Chen, S.P., et al. Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterology 149 (2015), 883–885.e9.
37. 37 Bashan, A., Gibson, T.E., Friedman, J., et al. Universality of human microbial dynamics. Nature 534 (2016), 259–262.
38. 38 Ridaura, V.K., Faith, J.J., Rey, F.E., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 2013, 341.
39. 39 Yissachar, N., Zhou, Y., Ung, L., et al. An Intestinal organ culture system uncovers a role for the nervous system in microbe-immune crosstalk. Cell 168 (2017), 1135–1148.
40. 40 Holmes, E., Li, J.V., Marchesi, J.R., et al. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab 16 (2012), 559–564.
41. 41 den Besten, G., Lange, K., Havinga, R., et al. Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. Am J Physiol Gastrointest Liver Physiol 305 (2013), G900–G910.
42. 42 Perry, R.J., Peng, L., Barry, N.A., et al. Acetate mediates a microbiome–brain–β-cell axis to promote metabolic syndrome. Nature 534 (2016), 213–217.
43. 43 De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156 (2014), 84–96.
44. 44 Vrieze, A., Out, C., Fuentes, S., et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J Hepatol 60 (2014), 824–831.
45. 45 Tang, W.H., Hazen, S.L., Microbiome, trimethylamine N-oxide, and cardiometabolic disease. Transl Res 179 (2017), 108–115.
46. 46 Zhu, W., Gregory Jill, C., Org, E., et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165 (2016), 111–124.
47. 47 Wang, Z., Roberts Adam, B., Buffa Jennifer, A., et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163 (2015), 1585–1595.
48. 48 Kuipers, F., Bloks, V.W., Groen, A.K., Beyond intestinal soap–bile acids in metabolic control. Nat Rev Endocrinol 10 (2014), 488–498.
49. 49 Buchwald, H., Oien, D.M., Metabolic/Bariatric Surgery Worldwide 2008. Obes Surg 19 (2009), 1605–1611.
50. 50 Ryan, K.K., Tremaroli, V., Clemmensen, C., et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 509 (2014), 183–188.
51. 51 Flynn, C.R., Albaugh, V.L., Cai, S., et al. Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. Nat Commun, 6, 2015, 7715.
52. 52 Zhang, H., DiBaise, J.K., Zuccolo, A., et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 106 (2009), 2365–2370.
53. 53 Liou, A.P., Paziuk, M., Luevano, J.-M., et al. Conserved Shifts in the Gut Microbiota Due to Gastric Bypass Reduce Host Weight and Adiposity. Sci Transl Med, 5, 2013 178ra41-178ra41.
54. 54 Hotamisligil, G., Shargill, N., Spiegelman, B., Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993), 87–91.
55. 55 Donath, M.Y., Targeting inflammation in the treatment of type 2 diabetes. Diabetes Obes Metab 15 (2013), 193–196.
56. 56 Cani, P.D., Amar, J., Iglesias, M.A., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007), 1761–1772.
57. 57 Singh, V., Chassaing, B., Zhang, L., et al. Microbiota-dependent hepatic lipogenesis mediated by stearoyl CoA desaturase 1 (SCD1) promotes metabolic syndrome in TLR5-deficient mice. Cell Metab 22 (2015), 983–996.
58. 58 Garidou, L., Pomié, C., Klopp, P., et al. The Gut microbiota regulates intestinal CD4 T cells expressing RORγt and controls metabolic disease. Cell Metab 22 (2015), 100–112.
59. 59 Amar, J., Serino, M., Lange, C., et al. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 54 (2011), 3055–3061.
60. 60 Denou, E., Lolmède, K., Garidou, L., et al. Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance. EMBO Molec Med 7 (2015), 259–274.
61. 61 Glassing, A., Dowd, S.E., Galandiuk, S., et al. Inherent bacterial DNA contamination of extraction and sequencing reagents may affect interpretation of microbiota in low bacterial biomass samples. Gut Pathogens, 8, 2016, 24.
62. 62 Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1131.
63. 63 Eiseman, B., Silen, W., Bascom, G.S., et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44 (1958), 854–859.
64. 64 van Nood, E., Vrieze, A., Nieuwdorp, M., et al. Duodenal infusion of donor feces for recurrent clostridium difficile. N Engl J Med 368 (2013), 407–415.
65. 65 Moayyedi, P., Surette, M.G., Kim, P.T., et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149 (2015), 102–109.e6.
66. 66 Rossen, N.G., Fuentes, S., van der Spek, M.J., et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 149 (2015), 110–118.e4.
67. 67 Vrieze, A., Van Nood, E., Holleman, F., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143 (2012), 913–916.e7.
68. 68 Alang, N., Kelly, C.R., Weight gain after fecal microbiota transplantation. Open Forum Infect Dis, 2, 2015, ofv004.
69. 69 Girotra, M., Garg, S., Anand, R., et al. Fecal microbiota transplantation for recurrent clostridium difficile infection in the elderly: long-term outcomes and microbiota changes. Digest Dis Sci 61 (2016), 3007–3015.
70. 70 Ott, S.J., Waetzig, G.H., Rehman, A., et al. Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile infection. Gastroenterology 152 (2017), 799–811.e7.
71. 71 Nguyen, T.L., Vieira-Silva, S., Liston, A., et al. How informative is the mouse for human gut microbiota research?. Dis Model Mech 8 (2015), 1–16.
72. 72 Khanna, S., Pardi, D.S., Kelly, C.R., et al. A Novel microbiome therapeutic increases gut microbial diversity and prevents recurrent clostridium difficile infection. J Infect Dis 214 (2016), 173–181.
73. 73 Bonder, M.J., Kurilshikov, A., Tigchelaar, E.F., et al. The effect of host genetics on the gut microbiome. Nat Genet 48 (2016), 1407–1412.
74. 74 Falony, G., Joossens, M., Vieira-Silva, S., et al. Population-level analysis of gut microbiome variation. Science 352 (2016), 560–564.